Scarica l'app Stockscreener
15.40
2.90%
-0.46
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
150,451 Shares in Avadel Pharmaceuticals PLC. $AVDL Acquired by Cubist Systematic Strategies LLC - MarketBeat
HC Wainwright Brokers Lift Earnings Estimates for AVDL - MarketBeat
Avadel: LUMRYZ Momentum And Pipeline Expansion Support Buy Rating - Seeking Alpha
Avadel Pharmaceuticals PLC. $AVDL Position Lifted by Two Seas Capital LP - MarketBeat
Invenomic Capital Management LP Takes Position in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Trexquant Investment LP Buys New Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Analysts Set Expectations for AVDL Q3 Earnings - MarketBeat
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
165,520 Stock Options: Avadel Pharmaceuticals Grants Major Inducement Awards to New Key Hires - Stock Titan
Russell Investments Group Ltd. Reduces Stock Holdings in Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Avadel Pharmaceuticals (NASDAQ:AVDL) Given New $36.00 Price Target at HC Wainwright - MarketBeat
What is Lifesci Capital's Estimate for AVDL Q2 Earnings? - MarketBeat
What is the earnings history of Avadel Pharmaceuticals plcMarket Volume Summary & Safe Entry Trade Reports - Lancaster City Council
Lifesci Capital Upgrades Avadel Pharmaceuticals (NASDAQ:AVDL) to Strong-Buy - MarketBeat
Avadel (AVDL) Licenses Valiloxybate and Unveils LUMRYZ Data at World Sleep 2025 - Yahoo Finance
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap DownHere's What Happened - MarketBeat
Is Avadel Pharmaceuticals plc currently under institutional pressure2025 Buyback Activity & Detailed Earnings Play Strategies - beatles.ru
Avadel Pharmaceuticals PLC. (NASDAQ:AVDL) Receives Consensus Rating of "Buy" from Analysts - MarketBeat
Multi Factor Analysis Ranks Avadel Pharmaceuticals plc as Strong BuyDividend Hike & Stepwise Trade Signal Implementation - beatles.ru
Avadel chief commercial officer resigns, stock down 14% - MSN
Will Avadel Pharmaceuticals plc continue its uptrendStop Loss & Free Weekly Watchlist of Top Performers - Newser
Is Avadel Pharmaceuticals plc a candidate for recovery playJuly 2025 EndofMonth & Reliable Volume Spike Trade Alerts - Newser
Insider Stock Buying Reaches US$761.7k On Avadel Pharmaceuticals - 富途牛牛
Caption Management LLC Buys 104,910 Shares of Avadel Pharmaceuticals PLC. $AVDL - MarketBeat
Smart tools for monitoring Avadel Pharmaceuticals plc’s price actionQuarterly Trade Review & Weekly Market Pulse Updates - Newser
Is a relief rally coming for Avadel Pharmaceuticals plc holdersCEO Change & Daily Profit Maximizing Tips - Newser
Will Avadel Pharmaceuticals plc benefit from macro trendsPortfolio Update Report & Advanced Swing Trade Entry Alerts - Newser
Avadel Pharmaceuticals at Wells Fargo Conference: Strategic Growth and Challenges - Investing.com UK
Avadel Pharmaceuticals Presents 17 Abstracts on LUMRYZ Efficacy at World Sleep 2025, Highlighting Benefits of Once-Nightly Sodium Oxybate for Narcolepsy Treatment - Quiver Quantitative
Avadel Pharmaceuticals to Present New Data on LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension at World Sleep 2025 - The Manila Times
Avadel to Present LUMRYZ Narcolepsy Data at World Sleep 2025 | AVDL Stock News - Stock Titan
Predicting Avadel Pharmaceuticals plc trend using moving averagesJuly 2025 Sector Moves & Real-Time Market Sentiment Alerts - Newser
Avadel Pharmaceuticals stock price target raised to $36 at H.C. Wainwright - Investing.com UK
Is Avadel Pharmaceuticals plc stock ready for a breakout2025 Market Outlook & Reliable Breakout Forecasts - Newser
Applying Elliott Wave Theory to Avadel Pharmaceuticals plcJobs Report & High Accuracy Swing Entry Alerts - Newser
Tick level data insight on Avadel Pharmaceuticals plc volatilityWeekly Volume Report & Daily Price Action Insights - Newser
Published on: 2025-09-04 22:28:10 - Newser
The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH - Sleep Review
Avadel licenses once-at-bedtime oxybate therapy from XWPharma - Investing.com India
Avadel Pharmaceuticals plc Testing Reversal Zone on Weekly ChartDividend Hike & Free Fast Entry Momentum Trade Alerts - beatles.ru
Avadel Pharmaceuticals (AVDL) Attracts Institutional Investment - MSN
Why Avadel Pharmaceuticals plc is moving todayJuly 2025 Technicals & AI Powered Buy/Sell Recommendations - Newser
Avadel licenses once-at-bedtime oxybate therapy from XWPharma By Investing.com - Investing.com Australia
Avadel secures rights to develop valiloxybate globally - Yahoo Finance
Sleep Disorder Market Heats Up with Avadel’s Global Grab for Valiloxybate - geneonline.com
Will Avadel Pharmaceuticals plc rebound enough to break evenJuly 2025 PostEarnings & Free AI Powered Buy and Sell Recommendations - Newser
Can you recover from losses in Avadel Pharmaceuticals plcWeekly Loss Report & Low Drawdown Investment Ideas - Newser
How to read the order book for Avadel Pharmaceuticals plcTrade Risk Report & Weekly Sector Rotation Insights - Newser
2.67%
0.04%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):